(Q35790787)

10 August 2017

1 reference

title

Colon cancer angiogenesis and antiangiogenic therapy (English)

1 reference

10 August 2017

main subject

angiogenesis inhibitor

1 reference

1 reference

Curtis J Wray

1

1 reference

10 August 2017

Horatio L Rilo

series ordinal

2

1 reference

10 August 2017

Syed A Ahmad

series ordinal

3

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

Expert Opinion on Investigational Drugs

10 August 2017

published in

1 reference

10 August 2017

volume

13

1 reference

10 August 2017

issue

6

1 reference

10 August 2017

page(s)

631-641

1 reference

What Is the Evidence That Tumors Are Angiogenesis Dependent?

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.6.631

The implications of angiogenesis for the biology and therapy of cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.6.631

Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.6.631

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.6.631

Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.6.631

Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.6.631

Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.6.631

Adhesion receptors and cell invasion: mechanisms of integrin-guided degradation of extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.6.631

Requirement of vascular integrin alpha v beta 3 for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.6.631

Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.6.631

Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.6.631

Therapies directed at vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.6.631

Design, synthesis, and evaluations of substituted 3-[(3- or 4-carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as inhibitors of VEGF, FGF, and PDGF receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.6.631

Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.6.631

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.6.631

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.6.631

Endostatin exhibits a direct antitumor effect in addition to its antiangiogenic activity in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.6.631

Interferon alfa-2a therapy for life-threatening hemangiomas of infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.6.631

Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.6.631

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.6.631

Organ targeting in vivo using phage display peptide libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.6.631

VASCULAR ENDOTHELIAL GROWTH FACTOR AS PROGNOSTIC FACTOR IN RENAL CELL CARCINOMA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.13.6.631

10.1517/13543784.13.6.631

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference